Welcome and Introduction

Welcome and Introduction

Kevin Crowley - Director of Nuclear and Radiation Studies Board

Hedvig Hricak - Memorial Sloan Kettering

Play Flash Video

Why and how to track radiation exposure

Why and how to track radiation exposure

Donald Miller - U.S. Food and Drug Administration,

Charles Miller - Centers for Disease Control & Prevention

Play Play Flash Video

Session 1: National and international efforts in volume and dose tracking

Moderator: Fred Mettler - University of New Mexico


Introduction to Session 1

Introduction to Session 1

Fred Mettler - University of New Mexico

Play Play Flash Video

1.1: IAEA activities and overview of global activities

1.1: IAEA activities and overview of global activities

Madan Rehani - International Atomic Energy Agency

Play Play Flash Video

1.2: Radiation exposures in medical imaging: FDA's past and present efforts

1.2: Radiation exposures in medical imaging: FDA's past and present efforts

David Spelic - U.S. Food and Drug Administration

Play Play Flash Video

1.3: Strategies to Minimize Patient Radiation Exposure in the Veterans Health Administration

1.3: Strategies to Minimize Patient Radiation Exposure in the Veterans Health Administration

Charles Anderson - Veterans Health Administration

Play Play Flash Video

1.4: American College of Radiology (ACR) dose index registry

1.4: American College of Radiology (ACR) dose index registry

Richard Morin - Mayo Clinic

Play Play Flash Video

Discussion Session 1

Discussion Session 1

Play Flash Video

Session 2: Appropriate Radiation Dose Metrics and Estimation Techniques

Moderator: Richard Morin - Mayo Clinic


Introduction to Session 2

Introduction to Session 2

Richard Morin - Mayo Clinic

Play Flash Video

2.1: Radiation Metrics in Medical Imaging

2.1: Radiation Metrics in Medical Imaging

Walter Huda - Medical University South Carolina

Play Play Flash Video

2.2: Patient Dose: What to Record and Track and the Role of Organ Dose

2.2: Patient Dose: What to Record and Track and the Role of Organ Dose

Michael McNitt-Gray - University of California, Los Angeles

Play Play Flash Video

2.3: Protocol optimization and dose variability for CT-guided interventions

2.3: Protocol optimization and dose variability for CT-guided interventions

Raymond Thornton - Memorial Sloan Kettering

Play Play Flash Video

Panel: Physician's perspective on what to report

Panel: Physician's perspective on what to report

Michael Lauer - National Heart, Lung, and Blood Institute and James Brink - Yale University

Play Play Flash Video

Discussion Session 2

Discussion Session 2

Play Flash Video

Session 3: Volume - methods for collecting and evaluating data

Moderator: Walter Huda - Medical University South Carolina


3.1: Measuring population utilization of medical diagnostic procedures: data sources and challenges

3.1: Measuring population utilization of medical diagnostic procedures: data sources and challenges

Walter Huda - Medical University South Carolina Mythreyi Bhargavan Chatfield - American College of Radiology

Play Play Flash Video

3.2: Automated electronic medical record (EMR) dose history extraction and monitoring

3.2: Automated electronic medical record (EMR) dose history extraction and monitoring

Aaron Sodickson - Brigham and Women's Hospital

Play Play Flash Video

3.3: Procedure volume trends in the United States and perspectives on large scale data collection

3.3: Procedure volume trends in the United States and perspectives on large scale data collection

Ashok Shah and Gail Prochaska - IMV Ltd

Play Play Flash Video

Panel: Manufacturers' perspective on what to report

Panel: Manufacturers' perspective on what to report

Richard Mather - Toshiba Medical Research Institute, Kenneth Denison - GE Healthcare, Katheryn Grant - Siemens Healthcare, and Dominic Siewko - Philips Healthcare

Play Play Flash Video

Discussion Session 3

Discussion Session 3

Play Flash Video

Closing Remarks and Adjournment

Closing Remarks and Adjournment

Hedvig Hricak - Memorial Sloan Kettering

Play Flash Video

Day 2: Session 4: Risk- What we know and what we need to know

Day 2: Session 4: Risk- What we know and what we need to know

Welcome Remarks: Barbara McNeil, Harvard Medical School

Moderator: Amy Berrington de González - National Cancer Institute

Play Play Flash Video

4.1: Understanding radiation-induced cancer risks at radiological doses

4.1: Understanding radiation-induced cancer risks at radiological doses

David Brenner - Columbia University

Play Play Flash Video

4.2: Non-cancer effects at radiological doses

4.2: Non-cancer effects at radiological doses

Kiyohico Mabuchi - National Cancer Institute

Play Play Flash Video

4.3: Patient's perspective

4.3: Patient's perspective

Gwen Darien- Samuel Waxman Cancer Research Foundation

Play Play Flash Video

Discussion Session 4

Discussion Session 4

Play Flash Video

Lessons learned from pediatrics

Lessons learned from pediatrics

Donald Frush - Duke University

Play Play Flash Video

Panel: Next Steps

Panel: Next Steps

Fred Mettler - University of New Mexico, Hedvig Hricak - Memorial Sloan Kettering, Barbara McNeil - Harvard Medical School, David Brenner - Columbia University, and Donald Frush - Duke University
Discussion
Closing Remarks and Adjournment Barbara McNeil - Harvard Medical School

Play Flash Video